🇺🇸 Nimotuzumab plus S1 in United States

Nimotuzumab plus S1 (Nimotuzumab plus S1) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Nimotuzumab plus S1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Nimotuzumab plus S1 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nimotuzumab plus S1 in United States?

Chinese PLA General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.